Jbt Marel Corp
10 nominees · 3 ballot items.
Elect ten directors; advisory approval of named executive officer compensation ('say on pay'); ratify PricewaterhouseCoopers LLP as independent auditor; consider any other business properly brought before the meeting.
Follow how the vote landed and what changed on Jbt Marel Corp’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot3
- 1
Election of Ten Directors
ManagementBoard: FORRe-election of ten director nominees each for one-year terms.
- 2
Advisory Vote to Approve Named Executive Officer Compensation (Say on Pay
ManagementBoard: FORNon-binding, advisory resolution to approve the compensation of the company's named executive officers as disclosed in the proxy statement.
- 3
Ratification of Appointment of Independent Registered Public Accounting Firm for 2026
ManagementBoard: FORRatify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for 2026.
Nominees on the ballot10
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | 10.4% | 5,421,852 | $693M |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.4% | 2,814,287 | $360M |
| 3 | PRICE T ROWE ASSOCIATES INC /MD/ | 5.2% | 2,684,949 | $343M |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 2,329,850 | $298M |
| 5 | T. Rowe Price Investment Management, Inc. | 4.0% | 2,076,753 | $266M |
| 6 | STATE STREET CORP | 3.8% | 1,997,155 | $255M |
| 7 | Lifeyrissjodur verzlunarmanna (Pension Fund of Commerce | 3.1% | 1,595,344 | $204M |
| 8 | BlackRock, Inc. | 2.9% | 1,500,336 | $192M |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 2.1% | 1,099,494 | $141M |
| 10 | Gildi - lifeyrissjodur | 2.0% | 1,067,147 | $133M |
Other Industrials sector meetings6
Upcoming shareholder meetings at Jbt Marel Corp’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Jbt Marel Corp 2026 annual meeting?
- Jbt Marel Corp (JBTM) holds its 2026 annual shareholder meeting on Thursday, May 14, 2026.
- What is the record date for the Jbt Marel Corp 2026 meeting?
- The record date for the Jbt Marel Corp 2026 meeting is Monday, March 16, 2026. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Jbt Marel Corp's 2026 meeting?
- The board is presenting 10 director nominees at the Jbt Marel Corp 2026 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Jbt Marel Corp 2026 meeting?
- Shareholders will vote on 3 proposals at the Jbt Marel Corp 2026 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.